Clearmind Medicine (CMND) Current Leases (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Current Leases of $41241.0 for Q2 2026, up 14.62% year-over-year from $35982.0 in Q2 2025, and up 417.0% quarter-over-quarter from $7977.0 in Q1 2026.
Clearmind Medicine (CMND) Current Leases (2022 - 2026) Analysis & Trends
Clearmind Medicine's Current Leases history runs 5 years deep, the most recent figure standing at $41241.0 for Q2 2026.
- In Q2 2026, Current Leases rose 14.62% year-over-year to $41241.0; the TTM figure through Apr 2026 stood at $41241.0 (up 14.62% YoY), while the FY2025 annual figure was $18800.0, down 48.81% from the prior year.
- Current Leases for Q2 2026 stood at $41241.0, up from $7977.0 in the prior quarter.
- The five-year high for Current Leases was $63707.0 in Q1 2024, with the low at $4941.0 in Q2 2023.
- The 5-year median for Current Leases is $35651.0 (2024), against an average of $30975.7.
- The sharpest annual moves came in 2024 and 2026: Current Leases surged 218.05% in 2024, then plunged 79.6% in 2026.
- Clearmind Medicine's Current Leases stood at $39451.0 in 2022, then plunged by 87.48% to $4941.0 in 2023, then soared by 643.29% to $36726.0 in 2024, then tumbled by 48.81% to $18800.0 in 2025, then surged by 119.37% to $41241.0 in 2026.
- Business Quant data shows CMND's Current Leases at $41241.0 in Q2 2026, $7977.0 in Q1 2026, and $18800.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | 41,241.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 41,241.00 |
| Jan 31, 2026 | 7,977.00 |
| Oct 31, 2025 | 18,800.00 |
| Jul 31, 2025 | 28,439.00 |
| Apr 30, 2025 | 35,982.00 |
| Jan 31, 2025 | 39,094.00 |
| Oct 31, 2024 | 36,726.00 |
| Jul 31, 2024 | 35,320.00 |
| Jan 31, 2024 | 63,707.00 |
| Apr 30, 2023 | 4,941.00 |
| Jan 31, 2023 | 20,030.25 |
| Oct 31, 2022 | 39,450.97 |